Innscitech

Innscitech InnSciTech is a community for pharmaceutical, biotech, and research professionals to share ideas, innovations, and technology trends.

Focused on science-driven progress, this group connects professionals for learning, collaboration, and knowledge sharing

Nobel Peace Prize 2025 live: Venezuela’s Maria Corina Machado winsThe prestigious Nobel Peace Prize for 2025 has been aw...
10/10/2025

Nobel Peace Prize 2025 live: Venezuela’s Maria Corina Machado wins

The prestigious Nobel Peace Prize for 2025 has been awarded at the Norwegian Nobel Institute in Oslo to Venezuelan opposition politician Maria Corina Machado. It is the highlight of the week of announcements from October 6 to 13.
A total of 338 nominations had been submitted for the award, including 244 individuals and 94 organisations

     The Nobel Peace Prize has been awarded 105 times to 142 Nobel Prize laureates between 1901 and 2024, 111 individual...
10/10/2025




The Nobel Peace Prize has been awarded 105 times to 142 Nobel Prize laureates between 1901 and 2024, 111 individuals and 31 organisations. Since the International Committee of the Red Cross has been awarded the Nobel Peace Prize three times (in 1917, 1944 and 1963), and the Office of the United Nations High Commissioner for Refugees has been awarded the Nobel Peace Prize two times (in 1954 and 1981), there are 28 individual organisations which have been awarded the Nobel Peace Prize. Click on the links to get more information.

https://www.nobelprize.org/prizes/lists/all-nobel-peace-prizes/

Cancer Uses Mitochondria to Reprogram Neighboring CellsA new discovery reveals how cancer cells can manipulate their sur...
10/10/2025

Cancer Uses Mitochondria to Reprogram Neighboring Cells

A new discovery reveals how cancer cells can manipulate their surroundings to support tumor growth. Recent research has shown that cancer cells can transfer mitochondria—the cell’s energy-producing organelles—to nearby noncancerous cells, effectively reprogramming them to favor tumor survival and expansion.

Scientists found that this mitochondrial transfer alters the metabolism and behavior of neighboring cells, converting them into “tumor-supportive” partners. These reprogrammed cells begin to produce nutrients, growth factors, and signaling molecules that help cancer cells resist stress, grow faster, and evade the immune system.

This finding changes how researchers view the tumor microenvironment, highlighting that cancer is not just a disease of individual cells but a cooperative ecosystem where energy and information are exchanged.

By blocking mitochondrial transfer or interfering with the metabolic changes it causes, future therapies might disrupt this cellular collaboration—potentially stopping cancer growth or improving the effectiveness of existing treatments.

Baxdrostat: A Promising New Option for Hard-to-Treat HypertensionA major step forward may be on the horizon for people s...
10/10/2025

Baxdrostat: A Promising New Option for Hard-to-Treat Hypertension

A major step forward may be on the horizon for people struggling with high blood pressure that doesn’t respond to standard therapy.

A recent clinical trial published on August 30 in the New England Journal of Medicine revealed encouraging results for baxdrostat, a novel drug from a new class known as aldosterone synthase inhibitors.

Baxdrostat works by blocking the enzyme that drives production of aldosterone, a hormone that can raise blood pressure by increasing sodium and water retention. By targeting this mechanism, the drug helps reduce blood pressure through a more specific and physiologic approach.

In the multicenter trial, patients with resistant hypertension—those whose blood pressure remained high despite taking at least three different antihypertensive drugs—received baxdrostat or a placebo.
• Those treated with baxdrostat experienced significantly greater reductions in systolic blood pressure compared to placebo.
• Importantly, the drug was well tolerated and did not cause major safety concerns, including no excessive drop in cortisol levels or potassium imbalance, which were potential risks with earlier compounds in this drug class.

Experts say the findings could mark a new era in hypertension management, offering hope for millions worldwide whose blood pressure remains uncontrolled despite current medications.

09/10/2025
08/10/2025



The Nobel Prize in Chemistry 2025 was awarded jointly to Susumu Kitagawa, Richard Robson and Omar M. Yaghi "for the development of metal–organic frameworks"

Nobel Prize in Physics 2025
08/10/2025

Nobel Prize in Physics 2025

Address

Sonargaon
1207

Alerts

Be the first to know and let us send you an email when Innscitech posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Innscitech:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram